top of page
Monitoring the proportion of the population infected by SARS-CoV-2
The Lancet Public Health Hozé N, Paireau J, Lapidus N, Tran Kiem C, Salje H, Gianluca Severi, Touvier M, Zins M, de Lamballerie X,...
Apr 7, 2021
Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana
Nat Commun Andronico A, Tran Kiem C, Paireau J, Succo T, Bosetti P, Lefrancq N, Nacher M, Djossou F, Sanna A, Flamand C, Salje H,...
Mar 12, 2021
Inhibition of the replication of SARSCoV-2 in human cells by the FDA-approved drug chlorpromazine
Int J Antimicrob Agents Plaze M, Attali D, Prot M, Petit AC, Blatzer M, Vinckiera F, Levillayer L, Chiaravalli J, Perin-Dureau F, Cachiai...
Mar 1, 2021
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study
Euro Surveill Bosetti P, Tran Kiem C, Yazdanpanah Y, Fontanet A, Lina B, Colizza V, Cauchemez S We used a mathematical model to evaluate...
Jan 7, 2021
Age-specific mortality and immunity patterns of SARS-CoV-2
Nature O’Driscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H Estimating the size of...
Nov 2, 2020
Age-specific mortality and immunity patterns of SARS-CoV-2
Published in Nature O’Driscoll M, Dos Santos GR, Wang L, Cummings DAT, Azman AS, Paireau J, Fontanet A, Cauchemez S, Salje H Estimating...
Nov 2, 2020
bottom of page